Bank of America
THRN

Bank of America’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Bank of America’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-69,582
Closed -$709K – 8412
2023
Q3 		$709K Sell
69,582
-106,915
-61% -$814K ﹤0.01% 5064
2023
Q2 		$830K Buy
176,497
+16,379
+10% +$75.3K ﹤0.01% 4917
2023
Q1 		$740K Sell
160,118
-63,312
-28% -$279K ﹤0.01% 5108
2022
Q4 		$811K Buy
223,430
+43,182
+24% +$191K ﹤0.01% 5012
2022
Q3 		$853K Sell
180,248
-2,003
-1% -$10.1K ﹤0.01% 4999
2022
Q2 		$882K Buy
182,251
+60,913
+50% +$370K ﹤0.01% 5020
2022
Q1 		$772K Buy
121,338
+59,450
+96% +$320K ﹤0.01% 5473
2021
Q4 		$385K Sell
61,888
-686,532
-92% -$5.37M ﹤0.01% 6084
2021
Q3 		$6.47M Buy
+748,420
New +$6.11M ﹤0.01% 3305

Bank of America's THRN Position: Q4 2023 in Review

Bank of America sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 69,582 shares — an estimated $709K sold.

Bank of America first reported a position in THRN in Q3 2021 and held it in 9 quarters. The position peaked at $6.47M in Q3 2021. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Bank of America reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bank of America sold 69,582 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $709K.
  • Bank of America first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Bank of America's Thorne Healthtech, Inc. Common Stock position peaked at $6.47M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.